Novo Nordisk Logo

China OKs Novo Nordisk's Type-2 diabetes treatm...

Novo Nordisk Logo Png

Novo Nordisk hits all-time high as oral obesity...

Novo Nordisk Research Centre opens in Oxford | ...

Novo Nordisk's results are stunning - and it co...

Signal: Novo Nordisk market cap higher than Dan...

NOVO NORDISK INC.: Novo Nordisk Launches Ozempi...

Novo Nordisk leaps on new obesity drug data | p...

Novo Nordisk launches once-a-week diabetes drug...

Novartis' Sandoz dips on debut after lower than...

Novo Nordisk

Novo Nordisk A/S Sees Unusually Large Options V...

Novo Nordisk submits diabetes pill for US approval

FID prosigue su larga colaboración con Novo Nor...

Novo Nordisk’s Global Commitment to Diabetes Ca...

Novo Nordisk experience big profit rise due to ...

Novo Nordisk - la compañia que trata la diabete...

Novo Nordisk to test anti-obesity molecule in t...

Novo Nordisk receives FDA approval for Wegovy™

First: Novo Nordisk India launches oral Semaglu...

Is Novo Nordisk Stock a Buy After its Collapse?...

Novo Nordisk Posts Record Growth as Demand For ...

Novo Nordisk

Novo Nordisk Logo Png

Novo Nordisk amplía sus fármacos contra la obes...